ArticleScientific reports2023

Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype.

Sandra Orrù et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.